Important Information

AMP 2014 Annual Meeting
AMP CELEBRATES 20 YEARS!
November 13 -15, 2014
For More Information

Corporate Workshop Day & Gala, November 12, 2014

Gaylord National Resort & Convention Center
National Harbor, MD (just outside of Washington, DC)

Special Features

AMP International
AMP Test Directory
Awards, Grants & Honors
Career Development
Membership Information
Online Member Directory
The Journal of Molecular Diagnostics
Trainee Programs
Web Library

How to Help

Corporate Support Opportunities
Donate to AMP

Volunteer

AP RSS Feed Linked In FaceBook Twitter
more information

Advocacy Home Page

AMP Press Releases

AMP Position Statements and Letters

 

 

 

 

AMP Position statements and letters

AMP Position Statements and Letters - 2009

 

2009 Title Keywords Committee
       

November

Letter to HHS Office for Civil Rights to support amending HIPAA Privacy Rule to implement GINA

 

Professional Relations

 

AMP urges federal agencies to implement GINA

 

Professional Relations

 

 

 

 

October

AMP reiterates its position on gene patents, direct-to-consumer marketing of genetic testing, and genetic nondiscrimination to the Secretary's Advisory Committee on Genetics, Health & Society (SACGHS) on October 8

 

Professional Relations

 

AMP lobbies for equitable reimbursement - AMP has been vigorously advocating with members of Congress for several months to revise or reject legislation that would eliminate the 14-day waiting period for a wide spectrum of molecular tests - for laboratories that are independent of the hospital where the specimen was collected and not under any arrangements.

 

Economic Affairs

 

 

 

 

September

Comments to CLIAC regarding ensuring laboratory testing quality during a public health emergency: AMP labs during the Spring 2009 H1N1 outbreak

 

Professional Relations

 

Comments to NIST Roadmap: "Measurement Science and Measurement Standards to Support Innovation in Healthcare

 

Professional Relations

 

Comments to AHRQ Draft Report on LDTs

 

Clinical Practice

 

 

 

 

August

Letter to Dr. Janet Woodcock encourages FDA to always identify a companion diagnostic on drug labeling by the biological description

 

Clinical Practice

 

 

 

 

June

AMP comments to the SACGHS

 

Professional Relations

 

AMP priorities for Comparative Effectiveness Research (CER)

 

Professional Relations

 

AMP Principles for Health Care Reform

 

Professional Relations

 

Comments to House Science & Technology Committee regarding the immediate and long-term needs for standards development in biotechnology at NIST

 

Clinical Practice

 

 

 

 

May

AMP comments to the SACGHS draft report on gene patents

 

Professional Relations

 

MEDCAC Comments

 

Economic Affairs

 

 

 

 

April

AMP responds to Genentech Citizen Petition

 

Professional Relations

 

AMP responds to Genentech Citizen Petition

 

Clinical Practice

 

 

 

 

March

AMP recommends to the IOM priorities for Stimulus Bill spending on comparative effectiveness research (CER)

 

Professional Relations

 

 

 

 

Feburary

Comments to NHGRI Regarding Long Range Planning

 

Clinical Practice

 

AMP Position on Genetic Ancestry Testing

 

Clinical Practice

 

MEDCAC Presentation

 

Economic Affairs

 

 

 

 

January

Comments on ACMG's Technical Standards and Guidelines for Myotonic Dystrophy Type 1 Testing

 

Clinical Practice

 

MEDCAC/CMS Letter

 

Economic Affairs